4.6.1.18 | serum |
RNase activities are significantly reduced in serum samples of patients with gastric cancer, liver cancer, pancreatic cancer, esophageal cancer, ovary cancer, cervical cancer, bladder cancer, kidney cancer and lung cancer, while only minor changes are found in serum of breast and colon cancer patients compared to healthy controls. No difference in serum RNase levels between patients with primary and metastatic colon cancer |
730787 |